Found 20 matching trials
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma PHASE2 The trial investigates a stage-adapted (stage IIA or IIB) de-escalation of ...
Show More Status
Active Not Recruiting
Location
Rotkreuzklinikum MĂŒnchen
Learn More & Join Trial
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers PHASE3 Study to evaluate the efficacy of treatment by radiotherapy and pembrolizum...
Show More Location
Institut Sainte Catherine
Learn More & Join Trial
INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy PHASE2 Elective nodal irradiation has been a longstanding standard-of-care in the ...
Show More Location
University of Texas Southwestern Medical Center - Dallas
Learn More & Join Trial
Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer PHASE2 Intensity modulated radiation therapy (IMRT) with or without chemotherapy (...
Show More Location
Rush University Medical Center
Learn More & Join Trial
A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients PHASE3 This is a Phase III, Randomized, Open-label, Efficacy and Safety Study of C...
Show More Location
The First Affiliated Hospital of Anhui Medical University, Department of Medical Oncology
Learn More & Join Trial
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma PHASE3 This phase III trial is studying the side effects and how well giving combi...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung PHASE3 This study will evaluate the anti-cancer effects of crizotinib when compare...
Show More Location
Tower Cancer Research Foundation
Learn More & Join Trial
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma PHASE2 Participants in this study have a type of cancer called squamous cell carci...
Show More Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill
Learn More & Join Trial
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) â„50% Locally Advanced NSCLC PHASE2 This is a phase II, multicenter, single-arm, non-blind study. To 21 patient...
Show More Location
Multiple Locations
Learn More & Join Trial
A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer PHASE2 Varian Medical Systems has recently deployed a completely novel radiation t...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial